How Much Weight Do You Lose on 10 mg Mounjaro?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide at the 10 mg maintenance dose represents a critical milestone in GLP-1 receptor agonist therapy for weight management. Clinical trials show that patients reaching this dose experience substantial metabolic changes, but the amount of weight loss depends on multiple factors beyond the dose itself.

Clinical Weight Loss Data on 10 mg Tirzepatide

The SURMOUNT clinical trial program evaluated tirzepatide across multiple dose levels, including the 10 mg weekly maintenance dose. Participants who completed the 68-week trial at 10 mg achieved an average weight loss of approximately 21% of their baseline body weight. This means a 200-pound person could expect to lose around 42 pounds on average, though results ranged from 15% to 22% depending on individual response.

Weight loss typically accelerates between weeks 4 and 16 as the body adjusts to tirzepatide's dual GLP-1 and GIP receptor activity. After week 16, the rate of loss often stabilizes but continues steadily through week 52 and beyond. Patients who maintain consistent medication use and lifestyle modifications tend to preserve their weight loss long-term, even as they reach a lower equilibrium.

Why Individual Results Vary at the Same Dose

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Baseline metabolic rate, dietary adherence, physical activity level, sleep quality, and stress hormones also shape weight loss trajectories. Patients who combine tirzepatide with structured calorie deficit and regular exercise typically lose 20–25% of body weight, while those relying on medication alone may see 12–18% loss. Age, previous weight loss attempts, and underlying insulin sensitivity further modify individual outcomes at the same dose.

Reaching and Maintaining the 10 mg Dose

Tirzepatide dosing begins at 2.5 mg weekly and increases by 2.5 mg every four weeks until reaching the 10 mg maintenance dose or the dose that produces optimal appetite suppression with tolerable side effects. Most patients reach 10 mg around week 16 of treatment. The gradual titration allows the gastrointestinal system to adapt and helps distinguish between expected nausea and intolerance.

Once at 10 mg, most patients continue this dose long-term because it typically provides the therapeutic sweet spot of appetite reduction, metabolic improvement, and manageable tolerability. Some individuals plateau in weight loss at 7.5 mg and choose to remain there, while others find they need the full 10 mg for sustained results. PlexusDx tailors dosing strategy based on your Precision Peptide Genetic Test results and monthly progress assessments.

Compounded Tirzepatide at PlexusDx: Access and Pricing

PlexusDx offers compounded tirzepatide injection prepared by licensed 503A compounding pharmacies, available in all 50 states without insurance or membership requirements. Compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and works identically to brand-name Mounjaro because it contains the same active pharmaceutical ingredient. HSA and FSA accounts are eligible, making treatment accessible to patients seeking personalized weight loss therapy.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose specifically on 10 mg tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is 10 mg the highest dose of tirzepatide?

Yes, 10 mg weekly is the maximum approved maintenance dose of tirzepatide. Some patients achieve their target weight loss at lower doses (5 mg or 7.5 mg) and choose to remain there rather than escalate further, while others require the full 10 mg for optimal appetite suppression and metabolic effect.

Can I get tirzepatide without a brand-name Mounjaro prescription?

Yes. PlexusDx compounded tirzepatide injection is prepared by licensed 503A compounding pharmacies and contains identical active pharmaceutical tirzepatide. It is $289 per month month-to-month across all 50 states without insurance, making it an accessible alternative to Mounjaro.

What side effects should I expect on 10 mg tirzepatide?

The most common side effects are nausea, vomiting, diarrhea, and constipation, typically mild to moderate and diminishing over 4–8 weeks. Serious side effects are rare but include pancreatitis and gallbladder issues in susceptible individuals. Your PlexusDx provider screens for contraindications and monitors tolerability at each dose increase.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes plus 10 additional metabolic pathways affecting appetite, energy expenditure, and medication responsiveness. Results identify whether you're likely a strong responder at 10 mg, a moderate responder, or might benefit from a different compound like oral semaglutide or a dual-compound protocol.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Mounjaro For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.